CONTENTS
ACKNOWLEDGEMENTS...................................................................................................I
1 INTRODUCTION...............................................................................................................................................1
Aim...........................................................................................................................................................................2
Cost-Effectiveness Analysis (CEA)..................................................................................................................2
Coronary Heart Disease (CHD).........................................................................................................................3
TheSWSAHS..........................................................................................................................................................4
Risk Factors..........................................................................................................................................................4
Risk Factors Used in this Analysis...................................................................................................................5
2 PREVIOUS CEAS ON NUTRITION INTERVENTIONS.............................................................................6
Weinstein and Stason (1985)...............................................................................................................................6
Kritiansen, Eggen and Thelle (1991)................................................................................................................8
Crowley, Dunt and Day (1995)..........................................................................................................................9
Hall et al (1988).................................................................................................................................................11
The Interventions in More Detail...................................................................................................................16
Some Key Issues for Each Intervention.................................................................................... 19
3 THE INTERVENTIONS.................................................................................................14
Theinterventiongroups..........................................................................................14
THE INTERVENTIONS IN MORE DETAILS...........................................................................16
4 COST-EFFECTIVENESS ANALYSIS...........................................................................................................21
Effectiveness......................................................................................................................................................21
Cost-effectiveness.............................................................................................................................................29
Sensitivity Analysis - Length of effectiveness...........................................................................................30
Sensitivity Analysis - Take-up rates of programs......................................................................................31
TAKE-UP RATE AMONGST GPS)...............................................................................................................................33
Summary of results...........................................................................................................................................33
5 DISCUSSION...................................................................................................................................................34
Healthy Public Policy......................................................................................................................................34
Building Partnerships.......................................................................................................................................35
Effectiveness and evidence: biomedical, clinical & social behaviour considerations.......................35
Behaviour modification....................................................................................................................................38
Portfolio Investment........................................................................................................................................40
Otherdiseases....................................................................................................................................................41
Equity...................................................................................................................................................................41
REFERENCES.....................................................................................................................................................43
Appendixa.......................................................................................................................................................54
Appendixb.......................................................................................................................................................55
Appendixc.......................................................................................................................................................65
More intriguing information
1. The name is absent2. Aktive Klienten - Aktive Politik? (Wie) Läßt sich dauerhafte Unabhängigkeit von Sozialhilfe erreichen? Ein Literaturbericht
3. The name is absent
4. Langfristige Wachstumsaussichten der ukrainischen Wirtschaft : Potenziale und Barrieren
5. Modelling the Effects of Public Support to Small Firms in the UK - Paradise Gained?
6. Job quality and labour market performance
7. ISSUES IN NONMARKET VALUATION AND POLICY APPLICATION: A RETROSPECTIVE GLANCE
8. The name is absent
9. The name is absent
10. REVITALIZING FAMILY FARM AGRICULTURE